{"id":"https://openalex.org/W1592594541","doi":"https://doi.org/10.1002/9783527665211.ch20","title":"\u03b2\u2010Secretase Inhibitors for the Treatment of Alzheimer's Disease: Preclinical and Clinical Inhibitors","display_name":"\u03b2\u2010Secretase Inhibitors for the Treatment of Alzheimer's Disease: Preclinical and Clinical Inhibitors","publication_year":2014,"publication_date":"2014-06-13","ids":{"openalex":"https://openalex.org/W1592594541","doi":"https://doi.org/10.1002/9783527665211.ch20","mag":"1592594541"},"language":"en","primary_location":{"id":"doi:10.1002/9783527665211.ch20","doi":"https://doi.org/10.1002/9783527665211.ch20","is_oa":false,"landing_page_url":"https://doi.org/10.1002/9783527665211.ch20","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Structure\u2010Based Design of Drugs and Other Bioactive Molecules","raw_type":"other"},"volume":{"id":"https://openalex.org/W3086353311","display_name":"Structure\u2010Based Design of Drugs and Other Bioactive Molecules"},"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041773055","display_name":"Arun Kumar Ghosh","orcid":"https://orcid.org/0000-0003-2472-1841","observed_orcids":["https://orcid.org/0000-0003-2472-1841"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arun K. Ghosh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5084867757","display_name":"Sandra Gemma","orcid":"https://orcid.org/0000-0002-8313-2417","observed_orcids":["https://orcid.org/0000-0002-8313-2417"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandra Gemma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"421","last_page":"447"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/beta-secretase-inhibitors","display_name":"beta-secretase inhibitors","score":0.9819999933242798},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9890000224113464},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.8700000047683716},{"id":"https://openalex.org/keywords/amyloid-precursor-protein","display_name":"amyloid precursor protein","score":0.5189999938011169},{"id":"https://openalex.org/keywords/x-ray-crystallography","display_name":"X-ray crystallography","score":0.699999988079071},{"id":"https://openalex.org/keywords/peptidomimetic-inhibitors","display_name":"peptidomimetic inhibitors","score":0.9729999899864197},{"id":"https://openalex.org/keywords/non-peptidic-inhibitors","display_name":"non-peptidic inhibitors","score":0.9760000109672546},{"id":"https://openalex.org/keywords/preclinical-drug-candidates","display_name":"preclinical drug candidates","score":0.5849999785423279}],"concepts":[{"id":"https://openalex.org/C124790011","wikidata":"https://www.wikidata.org/wiki/Q2069797","display_name":"Peptidomimetic","level":3,"score":0.8161913156509399},{"id":"https://openalex.org/C36103677","wikidata":"https://www.wikidata.org/wiki/Q4749551","display_name":"Amyloid precursor protein secretase","level":5,"score":0.520209014415741},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5154557824134827},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4921781122684479},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.4424162805080414},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37574025988578796},{"id":"https://openalex.org/C31705614","wikidata":"https://www.wikidata.org/wiki/Q423510","display_name":"Amyloid precursor protein","level":4,"score":0.28101083636283875},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.21402204036712646},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11826243996620178},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11363229155540466},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/9783527665211.ch20","doi":"https://doi.org/10.1002/9783527665211.ch20","is_oa":false,"landing_page_url":"https://doi.org/10.1002/9783527665211.ch20","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Structure\u2010Based Design of Drugs and Other Bioactive Molecules","raw_type":"other"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W1500978048","https://openalex.org/W1525574052","https://openalex.org/W1553011341","https://openalex.org/W1560487523","https://openalex.org/W1580678191","https://openalex.org/W1597559638","https://openalex.org/W1644122431","https://openalex.org/W1816679421","https://openalex.org/W1854324009","https://openalex.org/W1886532866","https://openalex.org/W1976333571","https://openalex.org/W1980119907","https://openalex.org/W1989607398","https://openalex.org/W1995805296","https://openalex.org/W2000227988","https://openalex.org/W2003283600","https://openalex.org/W2007421279","https://openalex.org/W2011303819","https://openalex.org/W2012552181","https://openalex.org/W2015587575","https://openalex.org/W2016584130","https://openalex.org/W2020265146","https://openalex.org/W2026031997","https://openalex.org/W2026053103","https://openalex.org/W2027853783","https://openalex.org/W2033354781","https://openalex.org/W2034355601","https://openalex.org/W2045391529","https://openalex.org/W2048966170","https://openalex.org/W2051268743","https://openalex.org/W2056461294","https://openalex.org/W2062283435","https://openalex.org/W2063472038","https://openalex.org/W2080225612","https://openalex.org/W2086951287","https://openalex.org/W2096410114","https://openalex.org/W2100307248","https://openalex.org/W2120987099","https://openalex.org/W2133019124","https://openalex.org/W2154345169","https://openalex.org/W2162815565","https://openalex.org/W2169152986"],"related_works":["https://openalex.org/W1936699800","https://openalex.org/W2054856801","https://openalex.org/W2561810844","https://openalex.org/W2056461294","https://openalex.org/W2169356930","https://openalex.org/W1816679421","https://openalex.org/W2791706511","https://openalex.org/W1999317462","https://openalex.org/W1995392491","https://openalex.org/W2327064237"],"abstract_inverted_index":{"This":[0],"chapter":[1,23],"provides":[2],"a":[3],"detailed":[4,30],"account":[5],"of":[6,9,19,27,34,42],"structure-based":[7],"design":[8,41],"\u03b2-secretase":[10,28],"inhibitors":[11],"including":[12],"preclinical":[13],"candidate":[14],"AZD3839":[15],"for":[16],"possible":[17],"treatment":[18],"Alzheimer's":[20],"disease.":[21],"The":[22],"covers":[24],"early":[25],"development":[26],"inhibitors,":[29],"X-ray":[31],"structural":[32],"studies":[33],"\u03b2":[35],"-secretase":[36],"and":[37,40,44],"inhibitor":[38],"complexes,":[39],"peptidomimetic":[43],"nonpeptide":[45],"inhibitors.":[46]},"counts_by_year":[],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2016-06-24T00:00:00"}